Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SFN contributors: mct/npt/pgu - updated : 26-06-2012
HGNC name stratifin
HGNC id 10773
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveesophagus   highly
 mouth   highly
Endocrinepancreas   highly
Nervousnervecranial nerve  highly
Reproductivemale systemprostate  highly
Skin/Tegumentskin   highly
Visualeyeanterior segmentcornea  
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Epithelialbarrier liningepidermisstratum basale 
Epithelialsecretoryglandularendocrine 
cells
SystemCellPubmedSpeciesStageRna symbol
 epithelial cell
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
mono polymer homomer , dimer
HOMOLOGY
interspecies homolog to murine Mkrn3
Homologene
FAMILY
  • 14.3.3 family
  • CATEGORY regulatory
    SUBCELLULAR LOCALIZATION extracellular
        intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    basic FUNCTION
  • may be involved in negative regulation of protein kinase activity, cell proliferation, signal transduction, regulation of cell cycle
  • implicated in G2/M cell cycle arrest by Tp53 (Kuroda 2007)
  • acts as a tumor suppressor and is often inactivated during tumor development
  • having function linked to epidermal stratification and differentiation in the skin (Xin 2010)
  • critical for regulating corneal epithelial proliferation and differentiation by regulating Notch signaling activity (Xin 2010)
  • important G2M cell cycle checkpoint regulator and its expression is induced by DNA damage stress through a TP53-dependent pathway (Xin 2010)
  • regulates corneal epithelial cell proliferation and differentiation by maintaining Notch activity (Xin 2010)
  • plays a critical role in retaining epithelial polarity, through its interaction with PARD3 (Ling 2010)
  • plays a critical role in retaining epithelial polarity
  • regulates cytokinesis and cell cycle arrest induced by DNA damage
  • maintains FOXO1 at a consistent level critical for normal B-cell antigen receptor signaling and B-cell survival
  • its levels are critical for maintaining TP53 activity in response to DNA damage and regulating signal mediators such as AKT1
  • TP63 and SFN play opposing roles in the development of skin tumors and the accumulation of TP63 is essential for Ras/SFN mutation-induced papilloma formation and squamous cell carcinoma carcinogenesis
  • intracellular, phosphoserine binding protein, playing a regulatory role in epidermal epithelial differentiation
  • CELLULAR PROCESS cell life, proliferation/growth
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling signal transduction
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with IRF6 for the keratinocyte proliferation-differentiation switch
  • target of CA11 (for degradation, leading to MDM2 stabilization)
  • binds to p37 AUF1, retains it in the cytoplasm probably by masking its NLS, and enhances rapid turnover of ARE (AU-rich destabilizing element)-mRNAs
  • targets RFWD2 for nuclear export, thereby preventing RFWD2-mediated TP53 nuclear export
  • LRFN4 complexed with SFN and NCK1 to mediate elongation in monocytic cells via RAC-1-mediated actin cytoskeleton reorganization
  • cell & other
    REGULATION
    induced by TP53 in response to DNA damage
    Other COPS6 associates with RFWD2 and is involved in SFN ubiquitin-mediated degradation
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    in mammary carcinoma by hypermethylation and invulval squamous neoplasia
    tumoral     --low  
    in prostate cancer
    tumoral     --low  
    involved in the uncontrolled cell cycle in intrahepatic cholangiocarcinoma and is a significant indicator of poor prognosis for patients with intrahepatic cholangiocarcinoma
    tumoral     --over  
    in gastric cancer, significantly correlated with clinical stage and tumor invasion
    tumoral     --over  
    hypomethylation of the promoter leads to increased expression in non-small cell lung cancer
    tumoral        
    epigenetic silencing of 14-3-3sigma might contribute to tumor progression in malignant melanoma via loss of cell cycle control, impaired cellular senescence program
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancerdigestivestomach
    therapeutic molecular target for gastric cancer
    ANIMAL & CELL MODELS